Akira Takemoto

Notable Response to Nivolumab During the Treatment of SMARCA4-Deficient Thoracic Sarcoma: A Case Report

Yuki Iijima, Rie Sakakibara, Masahiro Ishizuka et al. · Immunotherapy · 2020 · 60 citations

Medicine, Oncology, Pharmacology +17

Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

Hiroshi Urakawa, Tsukasa Yonemoto, Seiichi Matsumoto et al. · World Journal of Surgical Oncology · 2018 · 55 citations · Full text

Medicine, Oncology, Surgery +7

Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study

Yasuko Aoyagi, Yoshihito Kano, Kohki Tohyama et al. · PLoS ONE · 2022 · 41 citations · Full text

Medicine, Molecular Medicine, Oncology +14

A Pilot Study Analyzing the Clinical Utility of Comprehensive Genomic Profiling Using Plasma Cell-Free DNA for Solid Tumor Patients in Japan (PROFILE Study)

Shotaro Matsudera, Yoshihito Kano, Yasuko Aoyagi et al. · Annals of Surgical Oncology · 2021 · 13 citations

Medicine, Genetics, Oncology +17

Integrative genome‐wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma

Akira Takemoto, Kousuke Tanimoto, Seiichi Mori et al. · Cancer Science · 2021 · 13 citations · Full text

Medicine, Genetics, Oncology +17